Plant Extracted Natural Compounds Impact on Stage IV Breast Cancer Survival Time and Remission.
Status unconfirmed
Conditions studied: Breast Cancer
In brief
RATIONALE: Plant extracted natural compounds, in an adjunct therapy position, slow the growth and reproduction of Stage IV Breast Cancer tumor cells. May help eradicate different types of cancers. PURPOSE: The purpose of this randomized Phase I trial is to first IDENTIFY, through laboratory analysis and validating cellular biochemical pathways, and HELP CONTROL, using natural plant extracted compounds, G.R.A.S. (Generally Accepted As Safe), compounds, the reproduction, growth progress and metastasis of Stage IV Breast Cancer cells. The therapy position is adjunct to conventional therapies and in "one-off" trials have been excitingly effective for long-term survival. Novel use of bioactive GRAS compounds to augment and enhance conventional cancer therapies and as stand-alone parallel therapies.
Key facts
- Study ID
- NCT00910884
- Run by
- Brabant Research
- People needed
- 300
- Starts
- 2020-09-01
- Expected to finish
- 2021-09-01
- Last updated by the study team
- 2020-01-18
Who can join
Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Brabant Research, Incorporated — Spokane Valley, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.